rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lewis H. Titterton Jr.

Director

Company insider

Files Form 4 as: Chief Executive Officer, Anixa Biosciences; Director, Parkervision.

In numbers

Trades disclosed
213
Buys
80
Sells
1
Bought
$3.7M
Sold
$651K
Companies
2
Companies where not an officer
1
First trade
8 Feb 2011
Last trade
23 Sep 2026
Last filed
25 Sep 2026

Companies traded

Where they are an officer
ANIX Anixa BiosciencesDirector, Officer · Biotechnology · last 23 Sep 202679 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
ParkervisionDirector · Hardware, Devices & Storage · last 22 Jan 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
05Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month. 2 lines have no legible date and are left out.

Every trade

TradedCompanyWhatAmount
23 Sep 2026filed 25 Sep 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$132K49,036 at $2.69filing
23 Sep 2026filed 25 Sep 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$132K49,036 at $2.69filing
10 Sep 2026filed 14 Sep 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$27K10,000 at $2.73filing
10 Sep 2026filed 14 Sep 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$27K10,000 at $2.73filing
20 Jul 2026filed 20 Jul 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$42K12,000 at $3.47filing
20 Jul 2026filed 20 Jul 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$42K12,000 at $3.47filing
15 Jul 2026filed 16 Jul 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$9,1742,797 at $3.28filing
15 Jul 2026filed 16 Jul 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$9,1742,797 at $3.28filing
16 Jun 2026filed 17 Jun 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$7,4872,836 at $2.64filing
16 Jun 2026filed 17 Jun 2026ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Bought$7,4872,836 at $2.64filing
22 Jan 2026filed 26 Jan 2026Parkervisionoption or derivative · Hardware, Devices & StorageSEC FORM 4 Code A$89K370,000 at $0.24filing
22 Jan 2026filed 26 Jan 2026Parkervisionoption or derivative · Hardware, Devices & StorageSEC FORM 4 Code A$89K370,000 at $0.24filing
5 Jan 2026filed 6 Jan 2026ANIX Anixa Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
5 Jan 2026filed 6 Jan 2026ANIX Anixa Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
15 Dec 2025filed 16 Dec 2025ANIX Anixa Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—16,000 at $0.00filing
15 Dec 2025filed 16 Dec 2025ANIX Anixa BiosciencesBiotechnologySEC FORM 4 Code M$47K16,000 at $2.92filing
18 Nov 2025filed 18 Nov 2025ParkervisionHardware, Devices & StorageSEC FORM 4 Bought$1.0M4,761,905 at $0.21filing
7 Oct 2025filed 7 Oct 2025Parkervisionoption or derivative · Hardware, Devices & StorageSEC FORM 4 Code M$95K525,000 at $0.18filing
7 Oct 2025filed 7 Oct 2025Parkervisionoption or derivative · Hardware, Devices & StorageSEC FORM 4 Code M$55K275,000 at $0.20filing
7 Oct 2025filed 7 Oct 2025ParkervisionHardware, Devices & StorageSEC FORM 4 Code M$95K525,000 at $0.18filing

Sectors

Health Care80
Technology1

Buys in green, sells in red, by the company’s sector.

Related people

Amit KumarChief Executive Officer · Chief Executive Officer at Anixa Biosciences, filing Form 4 there in the last year
Michael CatelaniPresident, COO, & CFO · President, COO, & CFO at Anixa Biosciences, filing Form 4 there in the last year
Arnold M. BaskiesDirector · Director at Anixa Biosciences, filing Form 4 there in the last year
Emily GottschalkDirector · Director at Anixa Biosciences, filing Form 4 there in the last year